ABSENCE OF P53 GENE-MUTATIONS IN PRIMARY NASOPHARYNGEAL CARCINOMAS

被引:0
|
作者
SPRUCK, CH
TSAI, YC
HUANG, DP
YANG, AS
RIDEOUT, WM
GONZALEZZULUETA, M
CHOI, P
LO, KW
YU, MC
JONES, PA
机构
[1] UNIV SO CALIF,KENNETH NORRIS JR COMPREHENS CANC CTR,1441 EASTLAKE AVE,LOS ANGELES,CA 90089
[2] CHINESE UNIV HONG KONG,SHA TIN,HONG KONG
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alterations in the p53 tumor suppressor gene and Epstein-Barr virus status were investigated in 15 nasopharyngeal carcinoma (NPC) biopsies. 4 xenografts, and 2 cell lines from the Cantonese region of southern China. One other established NPC cell line obtained from a northern Chinese patient was also studied. Restriction fragment length polymorphism analysis revealed a loss of heterozygosity for chromosome 17p, where the p53 gene resides, in only one of 15 NPC biopsies. Polymerase chain reaction-single-stranded conformational polymorphism analysis and direct sequencing failed to detect sequence alterations in exons 5 through 8 of the p53 gene in the 15 tumors and in the 4 NPC xenografts, all of which tested positive for Epstein-Barr virus. In contrast, the 3 NPC cell lines were all negative for Epstein-Barr virus and contained G --> C transversions in the p53 gene, with cell lines CNE-1 and CNE-2 harboring identical AGA (arginine) to ACA (threonine) changes at codon 280. These results suggest that p53 inactivation is not a necessary component of nasopharyngeal carcinogenesis in Cantonese but may be important in the establishment of cell lines derived from these tumors.
引用
收藏
页码:4787 / 4790
页数:4
相关论文
共 50 条
  • [41] P53 AND K-RAS GENE-MUTATIONS IN CHOLANGIOCARCINOMA
    NAKEEB, A
    SLEBOS, RJC
    HRUBAN, RH
    DOOLEY, WC
    OFFERHAUS, GJA
    PITT, HA
    HEPATOLOGY, 1995, 22 (04) : 156 - 156
  • [42] GERMLINE P53 GENE-MUTATIONS IN SUBSETS OF GLIOMA PATIENTS
    KYRITSIS, AP
    BONDY, ML
    XIAO, M
    BERMAN, EL
    CUNNINGHAM, JE
    LEE, PS
    LEVIN, VA
    SAYA, H
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05): : 344 - 349
  • [43] P53 GENE-MUTATIONS IN SKIN CANCERS WITH UNDERLYING DISORDERS
    KANEKURA, T
    KANZAKI, T
    KANEKURA, S
    KAWAHARA, K
    NAKASHIMA, T
    KITAJIMA, I
    MARUYAMA, I
    JOURNAL OF DERMATOLOGICAL SCIENCE, 1995, 9 (03) : 209 - 214
  • [44] TP53 GENE-MUTATIONS AND PROTEIN ACCUMULATION IN PRIMARY VAGINAL CARCINOMAS
    SKOMEDAL, H
    KRISTENSEN, G
    HELLAND, A
    NESLAND, JM
    KOOI, S
    BORRESEN, AL
    HOLM, R
    BRITISH JOURNAL OF CANCER, 1995, 72 (01) : 129 - 133
  • [45] MUTATIONS OF THE P53 GENE IN CARCINOMAS OF THE URINARY SYSTEM
    SUZUKI, Y
    TAMURA, G
    ACTA PATHOLOGICA JAPONICA, 1993, 43 (12): : 745 - 750
  • [46] Absence of SDHD mutations in primary nasopharyngeal carcinomas
    Hui, ABY
    Lo, KW
    Chan, SYY
    Kwong, J
    Chan, ASC
    Huang, DP
    INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) : 875 - 877
  • [47] ABSENCE OF P53 GENE-MUTATIONS IN PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY (PML) - A DNA-SEQUENCING STUDY
    ARIZA, A
    VONUEXKULLGULDEBAND, C
    MATE, JL
    ISAMAT, M
    ROCA, X
    CRUZSANCHEZ, FF
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1995, 54 : S81 - S81
  • [48] ELEVATED CONTENT OF P53 PROTEIN IN THE ABSENCE OF P53 GENE-MUTATIONS AS A POSSIBLE PROGNOSTIC MARKER FOR HUMAN RENAL-CELL TUMORS
    CHEMERIS, G
    LOKTINOV, A
    REMPEL, A
    SCHWARZ, M
    BANNASCH, P
    VIRCHOWS ARCHIV, 1995, 426 (06) : 563 - 569
  • [49] ABSENCE OF RAS GENE-MUTATIONS IN EARLY GASTRIC CARCINOMAS
    CRAANEN, ME
    BLOK, P
    TOP, B
    BOERRIGTER, L
    DEKKER, W
    OFFERHAUS, GJA
    TYTGAT, GNJ
    RODENHUIS, S
    GUT, 1995, 37 (06) : 758 - 762
  • [50] P53 PROTEIN OVEREXPRESSION IN MELANOMAS AND NORMAL EPIDERMIS IS INFREQUENTLY RELATED TO P53 GENE-MUTATIONS
    POREMBA, C
    YANDELL, DW
    KAMANABROU, D
    BOCKER, W
    DOCKHORNDWORNICZAK, B
    LABORATORY INVESTIGATION, 1995, 72 (01) : A49 - A49